NCT03247647 is a NA clinical trial of Enhanced Intervention in Alcohol Abuse, sponsored by Brown University.

Who is sponsoring NCT03247647?

NCT03247647 is sponsored by Brown University.

What drugs are being tested in NCT03247647?

Interventions in NCT03247647: Enhanced Intervention, Standard Intervention.

What condition does NCT03247647 study?

NCT03247647 studies Alcohol Abuse.

Is NCT03247647 still recruiting?

NCT03247647 is currently completed. Last updated 19 September 2024.

Last reviewed 2024-09-19 · How we verify

NCT03247647

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Personal Values and Mandated Students

Completed NA Last updated 19 September 2024

What this trial tests

NA trial testing Enhanced Intervention in Alcohol Abuse in 486 participants. Completed in 30 January 2022.

Timeline

13 March 2018

Primary endpoint
30 January 2022

30 January 2022

Quick facts

Lead sponsor	Brown University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	486
Start date	13 March 2018
Primary completion	30 January 2022
Estimated completion	30 January 2022
Sites	2 locations across United States

Drugs / interventions tested

Enhanced Intervention
Standard Intervention

Conditions studied

Alcohol Abuse — all drugs for Alcohol Abuse →

Sponsor

Brown University

Who can join

Adults 18 to 24, any sex, with Alcohol Abuse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to examine the efficacy of an enhanced alcohol intervention among individuals who are mandated to complete an alcohol education activity as part of a university sanction.

Publications & conference data

6 peer-reviewed publications reference this trial (live from Europe PMC):

Use of protective behavioral strategies and blackout experience among mandated college students.
Carey KB, Tempchin J, DiBello AM, Mastroleo NR. · · 2022 · cited 11× · PMID 35512439 · DOI 10.1016/j.addbeh.2022.107340
Comparing Alcohol Use of Pre-COVID-Era and COVID-Era Cohorts of Mandated College Student Drinkers.
Wilson SE, Feltus SR, Brenman AM, Carey KB, et al · · 2022 · cited 9× · PMID 35838424 · DOI 10.15288/jsad.2022.83.480
Does self-affirmation augment the effects of a mandated personalized feedback intervention? A randomized controlled trial with heavy drinking college students.
Carey KB, DiBello AM, Magill M, Mastroleo NR. · · 2024 · cited 4× · PMID 38236233 · DOI 10.1037/adb0000989
Predictors of receptivity to an alcohol intervention among mandated students.
Carey KB, DiBello AM, Orazio EE, Hatch MR, et al · · 2021 · cited 3× · PMID 32795738 · DOI 10.1016/j.addbeh.2020.106605
Do hypothetical evaluations of alcohol related consequences change over time? Examining the influence of past and ongoing consequences.
Feltus SR, Mastroleo NR, Carey KB, DiBello AM, et al · · 2024 · PMID 38564985 · DOI 10.1016/j.addbeh.2024.108022
Values of College Students Mandated to an Alcohol Intervention: A Qualitative Examination.
Hatch MR, Wilson SE, Mastroleo NR, DiBello AM, et al · · 2022 · PMID 36315498 · DOI 10.1080/10826084.2022.2136492

Verify or expand the search:

Other trials of Enhanced Intervention

Trials testing the same drug.

NCT03887910 — Northwell Health Visits: A Family Connects Pilot Implementation at Northwell Health · NA · completed
NCT03541642 — PrEP Communication Intervention for Female Clients of a Needle Exchange · NA · completed

Other recruiting trials for Alcohol Abuse

Currently open trials in the same condition.

NCT07281261 — tAN for Substance Use Disorder · NA · recruiting
NCT07216872 — Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use · NA · recruiting
NCT06415721 — Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder · NA · recruiting
NCT05743699 — Adaptation and Evaluation of Bright Horizons · NA · recruiting
NCT06265506 — Virtual Incentive Treatment for Alcohol · NA · recruiting

Other Brown University trials

Trials by the same sponsor.

NCT07502872 — TPG: Tafasitamab, Polatuzumab Vedotin, and Glofitamab as First-line Therapy for Diffuse Large B-cell Lymphoma and High-g · Phase 2 · not yet recruiting
NCT07118618 — Probenecid Administration for Alcohol Craving and Consumption · Phase 2 · recruiting
NCT07398443 — Using Novel Behavioral Economic Measures to Characterize Dual Marijuana and Tobacco Use in Young Adults · NA · recruiting
NCT05901766 — Effect of Iodine-containing Multiple Micronutrient During Lactation on Infant Neurodevelopment · Phase 4 · not yet recruiting
NCT06974604 — Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03247647 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Brown University
Last refreshed: 19 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03247647.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing